SCHEMBL16091921

SCHEMBL16091921

CC(C)c1c(-c2ccc(F)c(Cl)c2)[nH]c2c(C#N)cnn2c1=O

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KDM5A P29375 4/20 0.40
▸ PLAT P00750 4/20 0.38
▸ PGR P06401 2/20 0.38
▸ MDM4 O15151 1/20 0.36
▸ MDM2 Q00987 1/20 0.36
▸ FNTA P49354 1/20 0.36
▸ FNTB P49356 1/20 0.36
▸ PGGT1B P53609 1/20 0.36
▸ RET P07949 2/20 0.35
▸ TGFBR1 P36897 1/20 0.35
▸ TGFBR2 P37173 1/20 0.35
▸ IDO1 P14902 1/20 0.35
▸ GRIN1 Q05586 1/20 0.35
▸ GRIN2B Q13224 1/20 0.35
▸ CACNA1H O95180 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16092509 0.91 KDM5A (0.38) KDM5APLATPGR
SCHEMBL16092357 0.91 KDM5A (0.40) KDM5APLATKDM4EALDH1A1TDP1
SCHEMBL16092523 0.87 KDM5A (0.49) KDM5APLATKDM4EALDH1A1TDP1
SCHEMBL16091922 0.87 KDM5A (0.40) KDM5APLATMDM4MDM2KDM4E
SCHEMBL16092358 0.86 GRM2 (0.43) KDM5APLATCACNA1HKDM4E
SCHEMBL16092518 0.86 KDM5A (0.37) KDM5APLATMDM4MDM2FNTA
SCHEMBL16092238 0.85 CSNK2A1 (0.39) KDM5APLAT
SCHEMBL16092424 0.85 KDM5A (0.42) KDM5APLATFNTAFNTBPGGT1B
SCHEMBL16092434 0.84 PLAT (0.38) KDM5APLAT
SCHEMBL17547806 0.84 KDM5A (0.38) KDM5ARET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10035801-B2 Pyrazolo compounds and uses thereof GENENTECH, INC. (US) 2018-07-31 — — US disclosed
US-10035801-B2 Pyrazolo compounds and uses thereof GENENTECH, INC. (US) 2018-07-31 — — US disclosed
US-20160060267-A1 PYRAZOLO COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2016-03-03 — — US disclosed
US-20160060267-A1 PYRAZOLO COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2016-03-03 — — US disclosed
WO-2015135094-A1 THERAPEUTIC COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2015-09-17 — — WO disclosed
WO-2014139326-A1 PYRAZOLO COMPOUNDS AND USES THEREOF GENENTECH, INC. (US) 2014-09-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10035801-B2 Pyrazolo compounds and uses thereof KDM5A, KDM5C, KDM5B KDM5A 1/4885PLAT 4107/4885PGR 2616/4885
US-20160060267-A1 PYRAZOLO COMPOUNDS AND USES THEREOF KDM5A, KDM5C, KDM5B KDM5A 1/4885PLAT 4107/4885PGR 2616/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback